JPS58210092A
(ja)
*
|
1982-05-31 |
1983-12-07 |
Dai Ichi Seiyaku Co Ltd |
ピリドベンズオキサジン誘導体およびその製造法
|
PH22140A
(en)
|
1982-06-29 |
1988-06-01 |
Daiichi Seiyaku Co |
Tricyclic compounds
|
JPS591489A
(ja)
*
|
1982-06-29 |
1984-01-06 |
Dai Ichi Seiyaku Co Ltd |
ピリドベンゾオキサジン誘導体
|
US5281612A
(en)
*
|
1982-09-09 |
1994-01-25 |
Warner-Lambert Company |
Naphthyridine antibacterial agents
|
IE55898B1
(en)
*
|
1982-09-09 |
1991-02-14 |
Warner Lambert Co |
Antibacterial agents
|
US4665079A
(en)
*
|
1984-02-17 |
1987-05-12 |
Warner-Lambert Company |
Antibacterial agents
|
JPS59116217A
(ja)
*
|
1982-12-22 |
1984-07-05 |
Dai Ichi Seiyaku Co Ltd |
マイコプラズマ感染症用薬
|
JPS59105303U
(ja)
*
|
1982-12-28 |
1984-07-16 |
埼玉機器株式会社 |
切削加工用刃物
|
US4473568A
(en)
*
|
1983-03-01 |
1984-09-25 |
Warner Lambert Company |
Antibacterial thiazolidine or thiomorpholine substituted quinolines
|
JPS6020840A
(ja)
*
|
1983-07-14 |
1985-02-02 |
Toshiba Mach Co Ltd |
工作機械の油温制御装置
|
US4730000A
(en)
*
|
1984-04-09 |
1988-03-08 |
Abbott Laboratories |
Quinoline antibacterial compounds
|
DE3333719A1
(de)
*
|
1983-09-17 |
1985-04-04 |
Bayer Ag |
Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
|
US4551456A
(en)
*
|
1983-11-14 |
1985-11-05 |
Merck & Co., Inc. |
Ophthalmic use of norfloxacin and related antibiotics
|
US4774246A
(en)
*
|
1984-01-26 |
1988-09-27 |
Abbott Laboratories |
Quinoline antibacterial compounds
|
US4571396A
(en)
*
|
1984-04-16 |
1986-02-18 |
Warner-Lambert Company |
Antibacterial agents
|
US4542133A
(en)
*
|
1984-04-26 |
1985-09-17 |
Abbott Laboratories |
Methylenedioxy quino-benoxazine derivatives and antibacterial use
|
JPH0665676B2
(ja)
*
|
1984-04-26 |
1994-08-24 |
アボツト ラボラトリーズ |
キノリン‐ベノキサジン抗菌性化合物
|
US4540694A
(en)
*
|
1984-04-26 |
1985-09-10 |
Abbott Laboratories |
1-Pyridine substituted quino-benoxazines and antibacterial use
|
US4607032A
(en)
*
|
1984-04-26 |
1986-08-19 |
Abbott Laboratories |
Quino-benoxazine antibacterial compounds
|
US4533663A
(en)
*
|
1984-04-26 |
1985-08-06 |
Abbott Laboratories |
Quino-benzothiazine antibacterial compounds
|
US4529725A
(en)
*
|
1984-04-26 |
1985-07-16 |
Abbott Laboratories |
1-Pyridine substituted quino-benzothiazine
|
US4528285A
(en)
*
|
1984-04-26 |
1985-07-09 |
Abbott Laboratories |
Methylenedioxy quino-benzothiazine derivatives
|
US4550104A
(en)
*
|
1984-07-20 |
1985-10-29 |
Warner-Lambert Company |
Antibacterial thiazolo-quinolines and thiazolo-naphthyridines
|
US4550103A
(en)
*
|
1984-07-20 |
1985-10-29 |
Warner-Lambert Company |
Antibacterial 1-oxo-benzoquinolizine-2-carboxylic acids
|
US4822801A
(en)
*
|
1984-07-20 |
1989-04-18 |
Warner-Lambert Company |
4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
|
US5097032A
(en)
*
|
1984-07-20 |
1992-03-17 |
Warner-Lambert Company |
Antibacterial agents - II
|
DE3571974D1
(en)
*
|
1984-12-06 |
1989-09-07 |
Pfizer |
Substituted dihydroquinolone carboxylic acids, anti-bacterial compositions containing them
|
JPS61180771A
(ja)
*
|
1985-01-05 |
1986-08-13 |
バイエル・アクチエンゲゼルシヤフト |
安定な抗バクテリア剤水溶液
|
DE3517709A1
(de)
*
|
1985-01-05 |
1986-07-10 |
Bayer Ag |
Basische zubereitungen von chinoloncarbonsaeuren
|
CA1253154A
(en)
*
|
1985-05-24 |
1989-04-25 |
Atsushi Takagi |
Benzo¬ij|quinolizine-2-carboxylic acid derivatives
|
NO166131C
(no)
*
|
1985-06-20 |
1991-06-05 |
Daiichi Seiyaku Co |
Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
|
ZA864518B
(en)
*
|
1985-06-20 |
1987-03-25 |
Daiichi Seiyaku Co |
Optically active pyridobenzoxazine derivatives and intermediates thereof
|
AU585995B2
(en)
*
|
1985-06-20 |
1989-06-29 |
Daiichi Pharmaceutical Co., Ltd. |
Optically active pyridobenzoxazine derivatives and intermediates thereof
|
DE3522406A1
(de)
*
|
1985-06-22 |
1987-01-02 |
Bayer Ag |
Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
|
DE3522405A1
(de)
*
|
1985-06-22 |
1987-01-02 |
Bayer Ag |
1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
|
DE3608745A1
(de)
*
|
1985-07-24 |
1987-01-29 |
Bayer Ag |
Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
|
IN166416B
(da)
*
|
1985-09-18 |
1990-05-05 |
Pfizer |
|
CA1306750C
(en)
|
1985-12-09 |
1992-08-25 |
Istvan Hermecz |
Process for the preparation of quinoline carboxylic acide
|
US5237060A
(en)
*
|
1985-12-10 |
1993-08-17 |
Bayer Aktiengesellschaft |
Process of preparing enantiomerically pure 1,8-bridged 4-quinolone-3-carboxylic acids
|
DE3543513A1
(de)
*
|
1985-12-10 |
1987-06-11 |
Bayer Ag |
Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
|
US4689325A
(en)
*
|
1985-12-23 |
1987-08-25 |
Abbott Laboratories |
Isoxazolo-pyrido-phenoxazine and isothiazolo-pyrido-phenoxazine derivatives
|
US4687770A
(en)
*
|
1985-12-23 |
1987-08-18 |
Abbott Laboratories |
Isoxazolo-pyrido-benzoxazine and isothiazolo-pyrido-benzoxazine derivatives
|
US4692454A
(en)
*
|
1986-02-03 |
1987-09-08 |
Warner-Lambert Company |
Opthalmic use of quinolone antibiotics
|
US5153204A
(en)
*
|
1986-03-01 |
1992-10-06 |
Bayer Aktiengesellschaft |
7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
|
DE3606698A1
(de)
*
|
1986-03-01 |
1987-09-03 |
Bayer Ag |
7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate
|
DE3623757A1
(de)
*
|
1986-07-15 |
1988-01-21 |
Bayer Ag |
Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel
|
EP0259804B1
(de)
*
|
1986-09-12 |
1993-11-18 |
F. Hoffmann-La Roche Ag |
Pyrido [3,2,1-ij]-1,3,4-benzoxadiazinderivate, Verfahren zu deren Herstellung, entsprechende pharmazeutische Präparate und im Verfahren verwendbare Zwischenprodukte
|
US4864023A
(en)
*
|
1986-09-12 |
1989-09-05 |
Hoffmann-La Roche Inc. |
Pyrido(3,2,1-IJ)-1,3,4-benzoxadiazine derivatives
|
JP2558107B2
(ja)
*
|
1986-12-18 |
1996-11-27 |
第一製薬株式会社 |
外用剤
|
EP0273399B1
(en)
*
|
1986-12-25 |
1994-08-17 |
Daiichi Pharmaceutical Co., Ltd. |
Optically active 2,3-dihydrobenzoaxine derivatives and process for preparing the same
|
EP0286802B1
(en)
*
|
1987-02-26 |
1993-06-23 |
Rohto Pharmaceutical Co., Ltd. |
Use of ofloxacin in treating or preventing locally periodontal disease
|
JPH01199979A
(ja)
*
|
1987-04-07 |
1989-08-11 |
Kanebo Ltd |
新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤
|
NO883398L
(no)
*
|
1987-08-03 |
1989-02-06 |
Daiichi Seiyaku Co |
Fremgangsmaate for fremstilling av benzoksazin-derivater.
|
JP2800939B2
(ja)
*
|
1987-08-31 |
1998-09-21 |
大日本製薬株式会社 |
三環式化合物、そのエステルおよびその塩
|
US4839355A
(en)
*
|
1987-09-09 |
1989-06-13 |
Sterling Drug Inc. |
Tricyclic-pyridinylquinoline compounds, their preparation and use
|
US4889857A
(en)
*
|
1987-10-12 |
1989-12-26 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Quinolonecarboxylic acid compounds and pharmaceutical use thereof
|
WO1989005643A1
(en)
*
|
1987-12-18 |
1989-06-29 |
Pfizer Inc. |
Heterocyclic-substituted quinoline-carboxylic acids
|
FI95567C
(fi)
*
|
1987-12-25 |
1996-02-26 |
Daiichi Seiyaku Co |
Propoksibentseenijohdannaisia ja menetelmä niiden valmistamiseksi
|
FR2634483B2
(fr)
*
|
1987-12-29 |
1994-03-04 |
Esteve Labor Dr |
Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
|
FR2625200A1
(en)
*
|
1987-12-29 |
1989-06-30 |
Esteve Labor Dr |
7-(1-Azetidinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their application as medicaments
|
US5173484A
(en)
*
|
1988-02-05 |
1992-12-22 |
Bayer Aktiengesellschaft |
Quinolone- and naphthyridone carboxylic acid derivatives, process for their production, antibacterial compositions and feed additives containing them
|
JPH01258620A
(ja)
*
|
1988-04-08 |
1989-10-16 |
Dai Ichi Seiyaku Co Ltd |
耳疾患用局所製剤
|
JP2844079B2
(ja)
*
|
1988-05-23 |
1999-01-06 |
塩野義製薬株式会社 |
ピリドンカルボン酸系抗菌剤
|
KR910003630B1
(ko)
*
|
1988-06-17 |
1991-06-07 |
한국과학기술원 |
벤조일 아세틱 에스테르 유도체 및 그 제조방법
|
US5175160A
(en)
*
|
1988-08-09 |
1992-12-29 |
Daiichi Pharmaceutical Co., Ltd. |
Antimicrobial agent for animals
|
MY104139A
(en)
*
|
1988-08-09 |
1994-02-28 |
Daiichi Seiyaku Co |
Antimicrobial agent for animals
|
JPH02157282A
(ja)
*
|
1988-12-12 |
1990-06-18 |
Wakunaga Pharmaceut Co Ltd |
新規ピリドベンゾオキサジン誘導体
|
FR2644455B1
(fr)
*
|
1989-03-16 |
1994-09-23 |
Esteve Labor Dr |
Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicaments
|
FR2654728B2
(fr)
*
|
1989-03-16 |
1994-09-23 |
Esteve Labor Dr |
Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicament.
|
FR2649106A2
(fr)
*
|
1989-06-29 |
1991-01-04 |
Esteve Labor Dr |
Derives d'acides pyridone carboxyliques azetidinyl substitues, leur preparation et leur application en tant que medicament
|
NO177302C
(no)
*
|
1989-03-16 |
1995-08-23 |
Esteve Labor Dr |
Analogifremgangsmåte til fremstilling av terapeutisk aktive substituerte azetidinylkinolon(naftyridon)karboksylsyrederivater
|
US5214051A
(en)
*
|
1989-08-01 |
1993-05-25 |
Pfizer Inc. |
Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed
|
US5385913A
(en)
*
|
1989-10-06 |
1995-01-31 |
Pfizer Inc. |
1,4-dihydro-4-oxo-3-quinoline derivatives as selectively toxic mammalian antibacterial agents
|
FR2655545B1
(fr)
|
1989-12-11 |
1994-06-10 |
Rhone Poulenc Sante |
Nouvelle application therapeutique des derives des fluoroquinolones.
|
TW208013B
(da)
*
|
1990-03-01 |
1993-06-21 |
Daiichi Co Ltd |
|
US5166203A
(en)
*
|
1990-08-30 |
1992-11-24 |
Kanebo, Ltd. |
Quinolinecarboxylic acid derivatives, antibacterial agent containing the same
|
US5308843A
(en)
*
|
1990-09-11 |
1994-05-03 |
Sterling Drug Inc. |
Method of inhibiting mammalian topoisomerase II and malignant cell growth in mammals, with substituted (S)-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4 ]-benzoxazine(and-benzothiazine)-6-carboxylic acids
|
FR2676445B1
(fr)
*
|
1991-05-16 |
1995-02-03 |
Esteve Labor Dr |
Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments.
|
DE4120646A1
(de)
*
|
1991-06-22 |
1992-12-24 |
Bayer Ag |
7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
|
DE4121214A1
(de)
*
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
WO1993005816A1
(en)
*
|
1991-09-17 |
1993-04-01 |
Alcon Laboratories, Inc. |
Compositions containing quinolone antibiotics and sulfonate of polystyrol
|
CA2125287A1
(en)
*
|
1992-10-07 |
1994-04-14 |
Juan Carlos Carretero Gonzalvez |
Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives
|
WO1994025464A1
(en)
*
|
1993-04-24 |
1994-11-10 |
Korea Research Institute Of Chemical Technology |
Novel quinolone carboxylic acid derivatives and process for preparing the same
|
US5532239A
(en)
*
|
1993-08-02 |
1996-07-02 |
Assistance Publique - Hopitaux De Paris |
Therapeutic application of fluoroquinolone derivatives
|
KR950018003A
(ko)
*
|
1993-12-09 |
1995-07-22 |
스미스클라인 비참 피엘씨 |
신규한 퀴놀론 유도체 및 그의 제조 방법
|
DE4424369A1
(de)
*
|
1994-07-11 |
1996-01-18 |
Bayer Ag |
Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
|
US5910498A
(en)
*
|
1994-10-20 |
1999-06-08 |
Wakunaga Seiyaku Kabushiki Kaisha |
Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
|
US5644056A
(en)
*
|
1995-06-07 |
1997-07-01 |
Hoechst Celanese Corporation |
Method of preparing 7,8-difluoro-2,3-dihydro-3-methyl-4H-1, 4-benzoxazine
|
DE69729565T2
(de)
|
1996-04-19 |
2005-06-09 |
Wakunaga Pharmaceutical Co., Ltd. |
Neue Pyridoncarbonsäure-Derivate oder Salze dieser Derivate und antibakterielle Mittel, die diese aktiven Wirkstoffe enthalten
|
KR100309871B1
(ko)
|
1999-02-24 |
2001-10-29 |
윤종용 |
(-)피리도벤즈옥사진 카르복실산 유도체의 제조방법
|
JP4694669B2
(ja)
|
1999-03-17 |
2011-06-08 |
第一三共株式会社 |
医薬組成物
|
US6552020B1
(en)
*
|
1999-07-30 |
2003-04-22 |
Allergan, Inc. |
Compositions including antibiotics and methods for using same
|
US6166012A
(en)
|
1999-07-30 |
2000-12-26 |
Allergan Sales, Inc. |
Antibiotic compositions and method for using same
|
MXPA02002220A
(es)
|
1999-09-02 |
2002-09-02 |
Wakunaga Pharma Co Ltd |
Derivados de acido quinolincarboxilico o su sal.
|
SE9904108D0
(sv)
|
1999-11-15 |
1999-11-15 |
New Pharma Research Ab |
Nya föreningar
|
US6608078B2
(en)
|
2000-05-08 |
2003-08-19 |
Wockhardt Limited |
Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
|
AU7326801A
(en)
|
2000-07-14 |
2002-01-30 |
Allergan Sales Inc |
Compositions containing therapeutically active components having enhanced solubility
|
US7098219B2
(en)
|
2000-08-01 |
2006-08-29 |
Wockhart Limited |
Inhibitors of cellular efflux pumps of microbes
|
ATE319710T1
(de)
|
2000-12-21 |
2006-03-15 |
Pharmacia & Upjohn Co Llc |
Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
|
US6878713B2
(en)
*
|
2001-04-25 |
2005-04-12 |
Wockhardt Limited |
Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
|
US6964966B2
(en)
|
2001-04-25 |
2005-11-15 |
Wockhardt Limited |
Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
|
US7425628B2
(en)
|
2001-10-03 |
2008-09-16 |
Teva Pharmaceutical Industries Ltd. |
Methods for the purification of levofloxacin
|
EP1992629A1
(en)
|
2001-10-03 |
2008-11-19 |
Teva Pharmaceutical Industries Ltd. |
Preparation of levofloxacin and forms thereof
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
CA2470495A1
(en)
*
|
2001-12-24 |
2003-07-17 |
Teva Pharmaceutical Industries Ltd. |
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
|
AU2003217676B2
(en)
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
WO2003099815A1
(en)
|
2002-05-28 |
2003-12-04 |
Wockhardt Limited |
Crystalline fluoroquinolone arginine salt form
|
DE10312346A1
(de)
*
|
2003-03-20 |
2004-09-30 |
Bayer Healthcare Ag |
Kontrolliertes Freisetzungssystem
|
US20040191332A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Allergan, Inc. |
Preserved ophthalmic compositions
|
US7439268B2
(en)
*
|
2003-07-18 |
2008-10-21 |
Idexx Laboratories |
Compositions containing prodrugs of florfenicol and methods of use
|
ES2332049T5
(es)
*
|
2003-08-07 |
2014-03-27 |
Allergan, Inc. |
Composiciones de administración de sustancias terapéuticas en los ojos
|
US20050049210A1
(en)
*
|
2003-08-27 |
2005-03-03 |
Idexx Laboratories, Inc. |
Methods for the controlled delivery of pharmacologically active compounds
|
PL214849B1
(pl)
*
|
2003-09-04 |
2013-09-30 |
Wockhardt Ltd |
Tetrahydrat soli kwasu benzochinolizyno-2-karboksylowego z arginina, sposób jego wytwarzania, kompozycja zawierajaca przedmiotowy tetrahydrat soli oraz jego zastosowanie
|
WO2005026145A2
(en)
*
|
2003-09-12 |
2005-03-24 |
Warner-Lambert Company Llc |
Quinolone antibacterial agents
|
DE10351448A1
(de)
|
2003-11-04 |
2005-06-09 |
Bayer Healthcare Ag |
Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
|
CN100412075C
(zh)
*
|
2004-06-22 |
2008-08-20 |
浙江医药股份有限公司新昌制药厂 |
左旋氧氟沙星和氧氟沙星的制备方法
|
DE102005055385A1
(de)
*
|
2004-12-09 |
2006-06-14 |
Bayer Healthcare Ag |
Arzneimittel zur hygienischen Applikation im Ohr
|
US8524735B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
US7498307B2
(en)
*
|
2005-06-17 |
2009-03-03 |
Michael Alan Sturgess |
Combinations of DnaK inhibitors with known antibacterial agents
|
WO2007097940A2
(en)
*
|
2006-02-13 |
2007-08-30 |
Trustees Of Boston University |
Reca inhibitors with antibiotic activity, compositions and methods of use
|
US20070197548A1
(en)
|
2006-02-17 |
2007-08-23 |
Murthy Yerramilli V S |
Fluoroquinolone compositions
|
US7973022B2
(en)
|
2006-02-17 |
2011-07-05 |
Idexx Laboratories, Inc. |
Fluoroquinolone carboxylic acid salt compositions
|
DE102006010642A1
(de)
*
|
2006-03-08 |
2007-09-27 |
Bayer Healthcare Aktiengesellschaft |
Arzneimittelformulierungen, enthaltend Fluorchinolone
|
DE102006010643A1
(de)
|
2006-03-08 |
2007-09-13 |
Bayer Healthcare Aktiengesellschaft |
Arzneimittel enthaltend Fluorchinolone
|
WO2008019292A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Trustees Of Boston University |
Compositions and methods for potentiating antibiotic activity
|
WO2008077643A1
(en)
*
|
2006-12-22 |
2008-07-03 |
Farmaprojects, S.A. |
Process for the preparation of an antibacterial quinolone compound
|
EP1939206A1
(en)
*
|
2006-12-22 |
2008-07-02 |
Farmaprojects, S.A. |
Process for the preparation of an antibacterial quinolone compound
|
DE102007026550A1
(de)
|
2007-06-08 |
2008-12-11 |
Bayer Healthcare Ag |
Extrudate mit verbesserter Geschmacksmaskierung
|
US7902227B2
(en)
*
|
2007-07-27 |
2011-03-08 |
Janssen Pharmaceutica Nv. |
C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
|
US7550625B2
(en)
*
|
2007-10-19 |
2009-06-23 |
Idexx Laboratories |
Esters of florfenicol
|
DE102007055341A1
(de)
*
|
2007-11-19 |
2009-05-20 |
Bayer Animal Health Gmbh |
Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
US7842714B2
(en)
*
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
KR20160150110A
(ko)
|
2008-10-07 |
2016-12-28 |
랩터 파마슈티컬스 인코포레이티드 |
약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
|
SI2346509T1
(sl)
|
2008-10-07 |
2020-08-31 |
Horizon Orphan Llc |
Inhalacija levofloksacina za zmanjšanje vnetja pljuč
|
US8658648B2
(en)
|
2008-12-05 |
2014-02-25 |
Designmedix, Inc. |
Modified chloroquines with single ring moiety or fused ring moiety
|
US8877945B2
(en)
|
2009-05-15 |
2014-11-04 |
Redx Pharma Limited |
Redox drug derivatives
|
IN2012DN02477A
(da)
|
2009-09-04 |
2015-08-21 |
Mpex Pharmaceuticals Inc |
|
WO2011034971A1
(en)
*
|
2009-09-15 |
2011-03-24 |
Designmedix, Inc. |
Modified fluoroquinolone compounds and methods of using the same
|
CN101747382B
(zh)
*
|
2009-12-29 |
2012-06-27 |
广东药学院 |
一种以喹诺酮类化合物为配体的钌多吡啶配合物及其制备方法和应用
|
KR20130041803A
(ko)
|
2010-04-07 |
2013-04-25 |
알러간, 인코포레이티드 |
안과 조성물을 위한 보존제의 조합
|
AU2011237677A1
(en)
|
2010-04-07 |
2012-11-08 |
Allergan, Inc. |
Combinations of preservative compositions for ophthalmic formulations
|
CN101880288B
(zh)
*
|
2010-07-12 |
2012-02-22 |
浙江东亚药业有限公司 |
一种氧氟沙星的合成方法
|
BR112013008834B1
(pt)
|
2010-10-12 |
2021-08-03 |
Bayer Intellectual Property Gmbh |
Produto mastigável macio e seu processo de preparação
|
WO2013157018A1
(en)
|
2012-04-18 |
2013-10-24 |
Indian Institute Of Technology Madras |
A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics
|
ES2848394T3
(es)
|
2012-12-19 |
2021-08-09 |
Bayer Animal Health Gmbh |
Comprimidos que tienen aceptación mejorada y buena estabilidad durante el almacenamiento
|
CN104098588B
(zh)
*
|
2013-04-02 |
2016-05-25 |
广州白云山医药集团股份有限公司白云山制药总厂 |
一类三环喹诺酮衍生物及其制备方法和用途
|
MD4291C1
(ro)
*
|
2013-12-27 |
2015-02-28 |
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова |
Preparat medicamentos pentru tratamentul otitelor
|
CN104402917A
(zh)
*
|
2014-12-02 |
2015-03-11 |
千辉药业(安徽)有限责任公司 |
一种新氧氟沙星中间体的制备方法
|
CN105037388A
(zh)
*
|
2015-08-28 |
2015-11-11 |
安徽环球药业股份有限公司 |
一种安妥沙星的制备方法
|
CN106674254B
(zh)
*
|
2016-12-21 |
2019-03-15 |
广东省中医院 |
一类喹诺酮羧酸化合物及其中间体、制备方法以及应用
|
CN106632444A
(zh)
*
|
2016-12-29 |
2017-05-10 |
千辉药业(安徽)有限责任公司 |
一种新氧氟沙星中间体的合成方法
|
GB201708606D0
(en)
*
|
2017-05-30 |
2017-07-12 |
King's College London |
Antibiotic resistance breakers
|
WO2018235103A1
(en)
|
2017-06-22 |
2018-12-27 |
Cipla Limited |
METHOD OF TREATING CANCER
|
JOP20180097B1
(ar)
*
|
2018-10-22 |
2023-03-28 |
Univ Of Jordan |
مشتقات 1.8 - نفثاريدين الغلايكوزيلية و طرق تحضيرها و استخدامها في معالجة الالتهابات الميكروبية
|
WO2020202239A1
(en)
*
|
2019-04-04 |
2020-10-08 |
The University Of Jordan |
Glycosylated 3-substituted fluoroquinolone derivatives, preparation methods thereof, and their use in the treatment of antimicrobial infections
|
EP4025220A4
(en)
*
|
2019-09-06 |
2023-10-04 |
Elanco US Inc. |
TASTY VETERINARY MEDICINAL COMPOSITIONS IN GRANULE FORM
|